Access brought to you by: LOCKSS

Cardiology Clinical Trials

STAR CAST: Preliminary Results of Trial to Regress Hypertension
Catheter Ablation of Atrial Fibrillation without Coumadin Discontinuation, Protects against Thromboembolic Complications
DE-MRI Quantification of Atrial Fibrosis Predicts Ablation Outcome in Patients with Atrial Fibrillation
FIRM-Guided Ablation of Stable Rotors and Focal Sources Can Eliminate PAF without PVI
Long AT/AF Episodes Associated with Adverse Clinical Events in ICD Patients
Novel Contact Force Catheters are Effective and Safe for Paroxysmal AF Ablation
Watchman Superior to Warfarin for Stroke Prophylaxis in Atrial Fibrillation
First-in-Man Results Show That a Leadless Catheter Pacemaker is Feasible, Safe, and Effective
Reablation Superior to Antiarrhythmic Drug Therapy after a Failed Ablation Procedure
Improving Clinician Adherence to Evidence-Based Recommendations Reduces Unnecessary ICD Shocks

Pages